News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Neil Schneider, ASA, MAAA

Articles by Neil Schneider, ASA, MAAA

Third-Party Validation of Observed Savings From an Oncology Pathways Program

ByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MD

June 18th 2013

Latest Updated Articles

Third-Party Validation of Observed Savings From an Oncology Pathways Program
Published: June 18th 2013 | Updated:

Trending on AJMC

Top 5 Most-Read CLL Articles of 2025

Top 5 Most-Read "5 Things" Articles of 2025

Visibility, Not Lesion Burden, Drives Distress in Alopecia Areata

Evidence Suggests Bidirectional Risk Between Ovarian, Colorectal Cancers

Sleep Apnea Risk Tied to 40% Higher Odds of Poor Mental Health

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.